Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women

Authors
Category Primary study
JournalInternational Journal of Women's Health
Year 2015
This article has no abstract
Epistemonikos ID: 18021f98e1e06e0d3f9808dbde5a4940b8701d18
First added on: Feb 07, 2025